Predicting Drug Disposition via Application of a Biopharmaceutics Drug Disposition Classification SystemBENET, Leslie Z.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 3, pp 162-167, issn 1742-7835, 6 p.Conference Paper

Biopharmaceutics classification by high throughput solubility assay and PAMPAOBATA, Kouki; SUGANO, Kiyohiko; MACHIDA, Minoru et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 2, pp 181-185, issn 0363-9045, 5 p.Article

Dutch Society of Clinical Pharmacology and BiopharmacyBritish journal of clinical pharmacology. 2010, Vol 70, Num 6, pp 918-931, issn 0306-5251, 14 p.Conference Paper

Commercialization of biopharmaceutical and bioindustrial proteins from plants : Genetic and metabolic engineering for value-added traitsHOWARD, John A.Crop science. 2005, Vol 45, Num 2, pp 468-472, issn 0011-183X, 5 p.Article

Polymeric delivery systems for biopharmaceuticalsDINARVAND, Rassoul; DORKOOSH, Farid; HAMIDI, Mehrdad et al.Biotechnology & genetic engineering reviews. 2004, Vol 21, pp 147-181, issn 0264-8725, 35 p.Article

Orphan products-pain relief for clinical development headaches: As the cost of clinical development rises, and products take longer to reach the market, the biotechnology industry may be wise to take a closer look at orphan drug indicationsMILNE, Christopher-Paul.Nature biotechnology. 2002, Vol 20, Num 8, pp 780-784, issn 1087-0156, 5 p.Article

On risk and plant-based biopharmaceuticalsPETERSON, Robert K. D; ARNTZEN, Charles J.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 2, pp 64-66, issn 0167-7799, 3 p.Article

Qu'est-ce qu'un biosimilaire ? = What are biosimilars ?POLACK, B.La Lettre du cancérologue (Boulogne). 2010, Num JUIN, pp 4-7, issn 1165-113X, 4 p., HSArticle

Prüfung auf Sterilität nach international harmonisierten Vorschriften = Testing for sterility according to the international harmonised regulationsSEYFARTH, Hanfried.Pharmazeutische Industrie. 2003, Vol 65, Num 12, pp 1263-1273, issn 0031-711X, 11 p.Article

Uncorking the biomanufacturing bottleneck: As biomanufacturing capacity becomes strained, several new methods for producing biologics are being investigated by biotechnology companiesDOVE, Alan.Nature biotechnology. 2002, Vol 20, Num 8, pp 777-779, issn 1087-0156, 3 p.Article

Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification SystemRAMIREZ, Elena; LAOSA, Olga; GUERRA, Pedro et al.British journal of clinical pharmacology. 2010, Vol 70, Num 5, pp 694-702, issn 0306-5251, 9 p.Article

Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified β-cyclodextrinsLIN, Hai-Shu; WEN, Wendy; LEONG, Yi et al.International journal of pharmaceutics. 2007, Vol 341, Num 1-2, pp 238-245, issn 0378-5173, 8 p.Article

Discovery strategies in a biopharmaceutical startup: Maximising your chances of success using computational filters : Computer aided drug designJENNINGS, A; TENNANT, M.Current pharmaceutical design. 2005, Vol 11, Num 3, pp 335-344, issn 1381-6128, 10 p.Article

Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public PolicyAMIDON, K. S; LANGGUTH, P; LENNERNÄS, H et al.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 3, pp 467-470, issn 0009-9236, 4 p.Article

Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain -Biopharmaceutic and pharmacokinetic challengesSRINIVAS, Nuggehally R.European journal of drug metabolism and pharmacokinetics. 2009, Vol 34, Num 1, pp 7-10, issn 0378-7966, 4 p.Article

An overview about biopharmaceutics in EuropeAIACHE, Jean-Marc.European journal of drug metabolism and pharmacokinetics. 2005, Vol 30, Num 1-2, pp 19-27, issn 0378-7966, 9 p.Article

Protein aggregation and its inhibition in biopharmaceuticsWEI WANG.International journal of pharmaceutics. 2005, Vol 289, Num 1-2, pp 1-30, issn 0378-5173, 30 p.Article

Recent developments in the use of transgenic plants for the production of human therapeutics and biopharmaceuticalsTELI, Nilesh P; TIMKO, Michael P.Plant cell, tissue and organ culture. 2004, Vol 79, Num 2, pp 125-145, issn 0167-6857, 21 p.Conference Paper

Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop summary reportCHEN, Mei-Ling; SHAH, Vinod P; HYSLOP, Terry et al.European journal of pharmaceutical sciences. 2011, Vol 44, Num 4, pp 506-513, issn 0928-0987, 8 p.Article

Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular StructureKHANDELWAL, Akash; BAHADDURI, Praveen M; CHENG CHANG et al.Pharmaceutical research. 2007, Vol 24, Num 12, pp 2249-2262, issn 0724-8741, 14 p.Article

Prediction of the permeability of drugs through study on quantitative structure- : permeability relationshipSEO JEONG JUNG; SUN OK CHOI; SO YOUNG UM et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 2, pp 469-475, issn 0731-7085, 7 p.Article

Current strategies for in vitro protein glycosylationKHMELNITSKY, Yuri L.Journal of molecular catalysis. B, Enzymatic. 2004, Vol 31, Num 4-6, pp 73-81, issn 1381-1177, 9 p.Article

Farmers to pharmasCOLLIS, Brad.Nature (London). 2004, Vol 429, Num 6991, pp A10-A13, issn 0028-0836, 3 p., SUPArticle

Improving the drug selection and development process for combination devicesHUPCEY, Maggie A. Z; EKINS, Sean.Drug discovery today. 2007, Vol 12, Num 19-20, pp 844-852, issn 1359-6446, 9 p.Article

Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugsYU, Lawrence X; CARLIN, Alan S; AMIDON, Gordon L et al.International journal of pharmaceutics. 2004, Vol 270, Num 1-2, pp 221-227, issn 0378-5173, 7 p.Article